Tenon Medical (NASDAQ:TNON – Get Free Report) and HeartSciences (NASDAQ:HSCS – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership.
Risk and Volatility
Tenon Medical has a beta of 1.35, meaning that its share price is 35% more volatile than the S&P 500. Comparatively, HeartSciences has a beta of 1.76, meaning that its share price is 76% more volatile than the S&P 500.
Valuation and Earnings
This table compares Tenon Medical and HeartSciences”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tenon Medical | $3.94 million | 0.63 | -$12.56 million | ($44.87) | -0.08 |
| HeartSciences | N/A | N/A | -$9.14 million | ($3.22) | -1.34 |
HeartSciences has lower revenue, but higher earnings than Tenon Medical. HeartSciences is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Tenon Medical and HeartSciences, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tenon Medical | 1 | 0 | 1 | 0 | 2.00 |
| HeartSciences | 1 | 0 | 1 | 0 | 2.00 |
HeartSciences has a consensus target price of $8.00, indicating a potential upside of 86.05%. Given HeartSciences’ higher possible upside, analysts plainly believe HeartSciences is more favorable than Tenon Medical.
Institutional and Insider Ownership
22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 17.7% of Tenon Medical shares are owned by insiders. Comparatively, 4.9% of HeartSciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Tenon Medical and HeartSciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tenon Medical | -257.85% | -907.60% | -124.84% |
| HeartSciences | N/A | -816.90% | -181.97% |
Summary
HeartSciences beats Tenon Medical on 6 of the 11 factors compared between the two stocks.
About Tenon Medical
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
About HeartSciences
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
